190 related articles for article (PubMed ID: 21087115)
1. Application of cytochrome P450 BM3 mutants as biocatalysts for the profiling of estrogen receptor binding metabolites of the mycotoxin zearalenone.
Reinen J; Kalma LL; Begheijn S; Heus F; Commandeur JN; Vermeulen NP
Xenobiotica; 2011 Jan; 41(1):59-70. PubMed ID: 21087115
[TBL] [Abstract][Full Text] [Related]
2. Novel oxidative metabolites of the mycoestrogen zearalenone in vitro.
Pfeiffer E; Heyting A; Metzler M
Mol Nutr Food Res; 2007 Jul; 51(7):867-71. PubMed ID: 17579896
[TBL] [Abstract][Full Text] [Related]
3. Aromatic hydroxylation is a major metabolic pathway of the mycotoxin zearalenone in vitro.
Pfeiffer E; Hildebrand A; Damm G; Rapp A; Cramer B; Humpf HU; Metzler M
Mol Nutr Food Res; 2009 Sep; 53(9):1123-33. PubMed ID: 19655315
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling of endocrine-disrupting compounds by on-line cytochrome p450 bioreaction coupled to on-line receptor affinity screening.
Van Liempd SM; Kool J; Meerman JH; Irth H; Vermeulen NP
Chem Res Toxicol; 2007 Dec; 20(12):1825-32. PubMed ID: 17975887
[TBL] [Abstract][Full Text] [Related]
5. On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators.
van Liempd SM; Kool J; Niessen WM; van Elswijk DE; Irth H; Vermeulen NP
Drug Metab Dispos; 2006 Sep; 34(9):1640-9. PubMed ID: 16790557
[TBL] [Abstract][Full Text] [Related]
6. Glucuronidation of zearalenone, zeranol and four metabolites in vitro: formation of glucuronides by various microsomes and human UDP-glucuronosyltransferase isoforms.
Pfeiffer E; Hildebrand A; Mikula H; Metzler M
Mol Nutr Food Res; 2010 Oct; 54(10):1468-76. PubMed ID: 20397195
[TBL] [Abstract][Full Text] [Related]
7. In vitro cytochrome p450 formation of a mono-hydroxylated metabolite of zearalenone exhibiting estrogenic activities: possible occurrence of this metabolite in vivo.
Bravin F; Duca RC; Balaguer P; Delaforge M
Int J Mol Sci; 2009 Apr; 10(4):1824-37. PubMed ID: 19468341
[TBL] [Abstract][Full Text] [Related]
8. Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis.
Frizzell C; Ndossi D; Verhaegen S; Dahl E; Eriksen G; Sørlie M; Ropstad E; Muller M; Elliott CT; Connolly L
Toxicol Lett; 2011 Oct; 206(2):210-7. PubMed ID: 21803136
[TBL] [Abstract][Full Text] [Related]
9. Genotoxicity and inactivation of catechol metabolites of the mycotoxin zearalenone.
Fleck SC; Hildebrand AA; Müller E; Pfeiffer E; Metzler M
Mycotoxin Res; 2012 Nov; 28(4):267-73. PubMed ID: 23606198
[TBL] [Abstract][Full Text] [Related]
10. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of zearalenone and zearalenols to their major glucuronide metabolites reduces estrogenic activity.
Frizzell C; Uhlig S; Miles CO; Verhaegen S; Elliott CT; Eriksen GS; Sørlie M; Ropstad E; Connolly L
Toxicol In Vitro; 2015 Apr; 29(3):575-81. PubMed ID: 25645597
[TBL] [Abstract][Full Text] [Related]
12. In vitro phase I metabolism of cis-zearalenone.
Drzymala SS; Herrmann AJ; Maul R; Pfeifer D; Garbe LA; Koch M
Chem Res Toxicol; 2014 Nov; 27(11):1972-8. PubMed ID: 25254638
[TBL] [Abstract][Full Text] [Related]
13. Aromatic hydroxylation and catechol formation: a novel metabolic pathway of the growth promotor zeranol.
Hildebrand A; Pfeiffer E; Metzler M
Toxicol Lett; 2010 Feb; 192(3):379-86. PubMed ID: 19931366
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of toxic effects of zearalenone and its two major metabolites alpha-zearalenol and beta-zearalenol on cultured human Caco-2 cells.
Abid-Essefi S; Bouaziz C; Golli-Bennour EE; Ouanes Z; Bacha H
J Biochem Mol Toxicol; 2009; 23(4):233-43. PubMed ID: 19705349
[TBL] [Abstract][Full Text] [Related]
15. Absorption and metabolism of the mycotoxin zearalenone and the growth promotor zeranol in Caco-2 cells in vitro.
Pfeiffer E; Kommer A; Dempe JS; Hildebrand AA; Metzler M
Mol Nutr Food Res; 2011 Apr; 55(4):560-7. PubMed ID: 21462323
[TBL] [Abstract][Full Text] [Related]
16. In vitro toxicological effects of estrogenic mycotoxins on human placental cells: structure activity relationships.
Prouillac C; Koraichi F; Videmann B; Mazallon M; Rodriguez F; Baltas M; Lecoeur S
Toxicol Appl Pharmacol; 2012 Mar; 259(3):366-75. PubMed ID: 22310176
[TBL] [Abstract][Full Text] [Related]
17. Efficient screening of cytochrome P450 BM3 mutants for their metabolic activity and diversity toward a wide set of drug-like molecules in chemical space.
Reinen J; van Leeuwen JS; Li Y; Sun L; Grootenhuis PD; Decker CJ; Saunders J; Vermeulen NP; Commandeur JN
Drug Metab Dispos; 2011 Sep; 39(9):1568-76. PubMed ID: 21673132
[TBL] [Abstract][Full Text] [Related]
18. Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes.
Yoon YJ; Kim KB; Kim H; Seo KA; Kim HS; Cha IJ; Kim EY; Liu KH; Shin JG
Drug Metab Dispos; 2007 Sep; 35(9):1518-24. PubMed ID: 17537876
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo induction of chromosome aberrations by alpha- and beta-zearalenols: comparison with zearalenone.
Ayed Y; Ayed-Boussema I; Ouanes Z; Bacha H
Mutat Res; 2011 Nov; 726(1):42-6. PubMed ID: 21889607
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of Zearalenone in the Rumen of Dairy Cows with and without Application of a Zearalenone-Degrading Enzyme.
Gruber-Dorninger C; Faas J; Doupovec B; Aleschko M; Stoiber C; Höbartner-Gußl A; Schöndorfer K; Killinger M; Zebeli Q; Schatzmayr D
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33499402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
